Isotretinoin
Questions | Reviews
Isotretinoin and alcohol consumption
Teenager, 18 year old male, going to Prom and is curently on Claravis. I'm concerend about physical reaction if alcohol is consumed. Please let me know.
by Angie R in Northbrook, IL, 05/18/2006
Isotretinoin killed my clitoris and Lord only knows what it did to my brain
HI, I am writing because i have been lately very concerned about my health, i have taken the first course of isotretinoin treatment for 20 weeks: 20mg / day the first 4 weeks and 10mg/day for 16 weeks, and from which i emerged with no serious damage, ...
by sanae in morocco, rabat, 09/20/2006
Classification: Vitamin A metabolite (antiacne, keratinization stabilizer) Action/Kinetics: Reduces sebaceous gland size, decreases sebum secretion, and inhibits abnormal keratinization. Approximately 25% of the PO dosage form is bioavailable. Peak plasma levels: 3 hr. Steady-state blood levels following 80 mg/day: 160 ng/mL. Nearly 100% bound to plasma protein. t 1/2: 10-20 hr. Metabolized in the liver to 4-oxo-isotretinoin, which is also active. Approximately equal amounts are excreted through the urine and in the feces. Uses: Severe recalcitrant cystic acne unresponsive to other therapy. Investigational: Cutaneous disorders of keratinization, cutaneous T-cell lymphoma (mycosis fungoides), leukoplakia, prevention of secondary primary tumors in those treated for squamous-cell carcinoma of the head and neck. Contraindications: Due to the possibility of fetal abnormalities or spontaneous abortion, women who are pregnant or intend to become pregnant should not use the drug. Certain conditions for use should be met in women with childbearing potential (see package insert). Use during lactation and in children. Special Concerns: Intolerance to contact lenses may develop. Side Effects: Skin: Cheilitis, skin fragility, pruritus, dry skin, desquamation of facial skin, drying of mucous membranes, brittle nails, photosensitivity, rash, hypo- or hyperpigmentation, urticaria, erythema nodosum, hirsutism, excess granulation of tissues as a result of healing, petechiae, peeling of palms and soles, skin infections, paronychia, thinning of hair, nail dystrophy, pyogenic granuloma, bruising. CNS: Headache, fatigue, pseudotumor cerebri (i.e., headaches, papilledema, disturbances in vision), depression. Ocular: Conjunctivitis, optic neuritis, corneal opacities, dry eyes, decrease in acuity of night vision, photophobia, eyelid inflammation, cataracts, visual disturbances. GI: Dry mouth, N&V;, abdominal pain, nonspecific GI symptoms, inflammatory bowel disease (including regional enteritis), anorexia, weight loss, inflammation and bleeding of gums. Neuromuscular: Arthralgia, muscle pain, bone and joint pain and stiffness, skeletal hyperostosis. CV: Flushing, palpitation, tachycardia. GU: White cells in urine, proteinuria, nonspecific urogenital findings, microscopic or gross hematuria, abnormal menses. Other: Epistaxis, dry nose and mouth, respiratory infections, disseminated herpes simplex, edema, transient chest pain, development of diabetes, hepatitis, hepatotoxicity, vasculitis, anemia, lymphadenopathy, flushing, palpitations. Laboratory Test Alterations: Plasma triglycerides, sedimentation rate, platelet counts, alkaline phosphatase, AST, ALT, GGTP, LDH, fasting blood glucose, uric acid in blood, cholesterol, CPK levels in clients who exercise vigorously. HDL, RBC parameters, WBC counts. Overdose Management: Symptoms: Abdominal pain, ataxia, cheilosis, dizziness, facial flushing, headache, vomiting. Symptoms are transient. Treatment: Symptoms are quickly resolved with drug cessation or decrease in dose.
Drug Interactions:
How Supplied: Capsule: 10 mg, 20 mg, 40 mg
Dosage
|
Write a first comment!